Task force shifts advice on aspirin use for preventing heart disease and strokes


The U.S. Preventive Services Task Force on Tuesday posted preliminary changes to its guidance on older adults taking aspirin to prevent heart disease and strokes.
The task force is an independent panel of national experts in disease prevention and evidence-based medicine. In its draft statement, which was posted so the public can submit comments on it through Nov. 8, the task force recommends that adults between the ages of 40 and 59 who do not have a history of cardiovascular disease but are at a higher risk of getting it talk with their doctors about whether they should start taking aspirin. This is the first time the panel has suggested adults in their 40s communicate with their physicians about whether to take aspirin for heart health, CNN reports.
Additionally, the draft states that adults 60 and older should not start taking aspirin to prevent heart disease and stroke, as there is new evidence indicating bleeding risks outweigh the potential benefits.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"The latest evidence is clear: Starting a daily aspirin regimen in people who are 60 or older to prevent a first heart attack or stroke is not recommended," task force member Dr. Chien-Wen Tseng said in a statement. "However, this task force recommendation is not for people already taking aspirin for a previous heart attack or stroke. They should continue to do so unless told otherwise by their clinician."
Heart disease is the leading cause of death in the United States, causing roughly 1 in 4 deaths.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
'A symbol of the faceless corporate desire'
Instant Opinion Opinion, comment and editorials of the day
-
Say farewell to summer at these underrated US lakes
The Week Recommends Have one last blast
-
Truck drivers are questioning the Trump administration's English mandate
Talking Points Some have praised the rules, others are concerned they could lead to profiling
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC